Skip to main content
Equibles

Jerzy (George) Gumulka

Board Member

CNS Pharmaceuticals, Inc. (CNSP)

Equibles does not estimate personal net worth.

Get an email with a short summary when CNS Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get CNSP alerts

About Jerzy (George) Gumulka

Jerzy (George) Gumulka is recorded as Board Member at CNS Pharmaceuticals, Inc. (CNSP) since November 17, 2025. CNS Pharmaceuticals, Inc. reported in an 8-K filed May 4, 2026 that Jerzy (George) Gumulka resigned as member of the Company's Board of Directors, effective May 4, 2026. CNS Pharmaceuticals, Inc. reported in an 8-K filed November 21, 2025 that Jerzy (George) Gumulka was appointed Director, effective November 17, 2025. CNS Pharmaceuticals, Inc. reported in an 8-K filed May 3, 2024 that Jerzy (George) Gumulka was appointed Director, effective April 30, 2024. Equibles holds 4 filed executive changes naming Jerzy (George) Gumulka; each is listed under recent activity with its source filing. CNS Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CNS Pharmaceuticals, Inc. includes Rami Levin (CEO and Board Member), Faith Charles (Chairman and Board Member), Steve O'Loughlin (CFO) and 7 others.

“On May 4, 2026, Jerzy (George) Gumulka resigned as a member of the Company's Board of Directors (the "Board").”
CNS Pharmaceuticals, Inc. Form 8-K, filed May 4, 2026 · Read the filing
“The Company's stockholders elected John Climaco, Jerzy (George) Gumulka, Jeffry R. Keyes, Faith Charles, Bettina Cockroft, and Amy Mahery, each to serve until the 2026 Annual Meeting of Stockholders or until such person's successor is qualified and elected, by the following vote:”
CNS Pharmaceuticals, Inc. Form 8-K, filed November 21, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at CNS Pharmaceuticals, Inc.

Recent activity